🇺🇸 FDA
Pipeline program

ZD6474

2005-0825

Phase 2 small_molecule completed

Quick answer

ZD6474 for Lung Cancer is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Lung Cancer
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials